» Articles » PMID: 21541737

[Treatment Strategies for Chronic Total Occlusion: Current Status and Outlook]

Overview
Journal Herz
Date 2011 May 5
PMID 21541737
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

The present article discusses the current status of treatment strategies for chronic total occlusion (CTO) and the prospects offered by new therapies. The indication for revascularisation recognized in the current European guidelines includes the presence of typical symptoms and evidence of ischemia of over 10% of the total myocardium, while in patients with multiple vascular diseases the aim is complete revascularisation. Although the vast majority of patients with CTO fulfil these criteria, they are currently not receiving interventional treatment as frequently as expected. The reasons often given for this include the low success rates and high recurrence rates. However, both problems have been improved by drug-eluting stents (DES) on the one hand and by wire techniques and strategies on the other, such that results almost comparable with non-occluded coronary lesions can be achieved. While more advanced approaches like retrograde recanalization should be restricted to specialized centres, marked improvements can be achieved even without these special techniques by means of consistent further training and the application of modern techniques. Despite the aggressiveness of these approaches to pass through an occluded artery, the complication rate is not higher than with non-occluded lesions when the specific complications of recanalization are avoided in a careful approach. Further technical improvements are expected with the use of modern imaging techniques such as intravascular ultrasound and high-resolution CT imaging of coronary arteries.

Citing Articles

A comparison of procedural success rate and long-term clinical outcomes between in-stent restenosis chronic total occlusion and de novo chronic total occlusion using multicenter registry data.

Lee S, Cho J, Kim J, Lee H, Yang J, Park J Clin Res Cardiol. 2019; 109(5):628-637.

PMID: 31552494 PMC: 7182633. DOI: 10.1007/s00392-019-01550-7.


Chronic total coronary occlusion recanalization: Current techniques and new devices.

Gulker J, Bansemir L, Klues H, Bufe A J Saudi Heart Assoc. 2017; 29(2):110-115.

PMID: 28373785 PMC: 5366668. DOI: 10.1016/j.jsha.2016.08.003.

References
1.
Hannan E, Racz M, Holmes D, King 3rd S, Walford G, Ambrose J . Impact of completeness of percutaneous coronary intervention revascularization on long-term outcomes in the stent era. Circulation. 2006; 113(20):2406-12. DOI: 10.1161/CIRCULATIONAHA.106.612267. View

2.
Werner G . The BridgePoint devices to facilitate recanalization of chronic total coronary occlusions through controlled subintimal reentry. Expert Rev Med Devices. 2010; 8(1):23-9. DOI: 10.1586/erd.10.76. View

3.
Reifart N, Hauptmann K, Rabe A, Enayat D, Giokoglu K . Short and long term comparison (24 months) of an alternative sirolimus-coated stent with bioabsorbable polymer and a bare metal stent of similar design in chronic coronary occlusions: the CORACTO trial. EuroIntervention. 2010; 6(3):356-60. DOI: 10.4244/EIJV6I3A59. View

4.
Gunning M, Williams I, Jewitt D, Shah A, Wainwright R, Thomas M . Coronary artery perforation during percutaneous intervention: incidence and outcome. Heart. 2002; 88(5):495-8. PMC: 1767399. DOI: 10.1136/heart.88.5.495. View

5.
Hannan E, Wu C, Walford G, Holmes D, Jones R, Sharma S . Incomplete revascularization in the era of drug-eluting stents: impact on adverse outcomes. JACC Cardiovasc Interv. 2009; 2(1):17-25. DOI: 10.1016/j.jcin.2008.08.021. View